Table 1.
Clinical characteristics
| Items | CHD patients (N = 220) | Control subjects (N = 200) | P value |
|---|---|---|---|
| Demographic characteristics | |||
| Age (y), mean ± SD | 62.8 ± 9.4 | 59.7 ± 9.0 | .001 |
| Gender, no. (%) | |||
| Female | 37 (16.8) | 43 (21.5) | .222 |
| Male | 183 (83.2) | 157 (78.5) | |
| BMI (kg/m2), mean ± SD | 23.7 ± 2.7 | 23.4 ± 2.9 | .264 |
| CHD risk factors | |||
| Smoke, no. (%) | 96 (43.6) | 75 (37.5) | .201 |
| Family history of CHD, no. (%) | 48 (21.8) | 32 (16.0) | .129 |
| Hypertension, no. (%) | 173 (78.6) | 139 (69.5) | .032 |
| Hyperlipidemia, no. (%) | 110 (50.0) | 86 (43.0) | .151 |
| Hyperuricemia, no. (%) | 84 (38.2) | 63 (31.5) | .152 |
| Diabetes mellitus, no. (%) | 53 (24.1) | 29 (14.5) | .013 |
| Gensini score, median (IQR) | 39.5 (19.3‐59.8) | 1.0 (0.0‐2.0) | <.001 |
| Biochemical indexes | |||
| FBG (mmol/L), mean ± SD | 5.7 ± 1.1 | 5.4 ± 1.1 | .012 |
| TG (mmol/L), mean ± SD | 1.8 ± 0.8 | 1.7 ± 0.8 | .111 |
| TC (mmol/L), mean ± SD | 4.7 ± 1.0 | 4.6 ± 1.0 | .183 |
| LDL‐C (mmol/L), mean ± SD | 3.0 ± 0.7 | 2.9 ± 0.7 | .098 |
| HDL‐C (mmol/L), mean ± SD | 1.1 ± 0.3 | 1.2 ± 0.3 | .004 |
| Scr (μmol/L), mean ± SD | 77.3 ± 15.2 | 75.1 ± 13.9 | .126 |
| SUA (μmol/L), mean ± SD | 346.2 ± 78.1 | 335.3 ± 74.1 | .145 |
| CRP (mg/L), median (IQR) | 16.9 (12.3‐22.6) | 7.3 (3.2‐11.2) | <.001 |
Abbreviations: BMI, body mass index; CHD, coronary heart disease; CRP, C‐reactive protein; FBG, fasting blood glucose; HDL‐C, high‐density lipoprotein cholesterol; IQR, interquartile range; LDL‐C, low‐density lipoprotein cholesterol; Scr, serum creatinine; SD, standard deviation; SUA, serum uric acid; TC, total cholesterol; TG, triglyceride.